NOT-DA-20-047
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
| NIDA
| Applications in response to this NOSI must be submitted using the following targeted funding opportunity: PA-18-935 is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
PA-20-272 is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant.
Due Date: applications will be accepted on a rolling basis through March 31, 2021.
|
NOT-TR-20-011
| Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
| NCATS
| CTSA (CTRI) award specific. PA-20-272 for UL1, U01, and R21 awards;
PAR-19-099 for U01 specific awards;
PAR-19-100 for R21 specific awards;
PAR-19-337 for UL1 specific awards.
- Update:
NOT-TR-20-018 expands the eligibility and activity codes to include U24 parent awards.
Due Date: varies per award mechanism and FOA. See NOSI.
|
NOT-GM-20-025
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
| NIGMS
| NIGM issued this NOSI to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19). Applications in response to this NOSI must be submitted to PA-18-935 which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
Due Date: applications will be accepted on a rolling basis from March 25, 2020 to February 5, 2021.
|
NOT-AG-20-022
| Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
| NIA
| Administrative supplement work that is proposed through
PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through
PA-18-935. An
FAQ page was created to assist those interested in applying to this NOSI. It can be found
here.
Due Date: applications will be accepted on a rolling basis from April 6, 2020 through May 1, 2021.
|
NOT-TR-20-016
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
| NCATS
| Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent:
PA-20-272.
Due Date: applications will be accepted on a rolling basis from May 15, 2020 through January 25, 2022.
|
NOT-MH-20-047
|
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
| NIMH
NIA
NIAAA
NIMHD
ODP
| Administrative supplement work that is proposed through
PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935.
Due Date: applications will be accepted on a rolling basis through April 15, 2021.
|
NOT-TR-20-017
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
| NCATS
| PA-20-135 or its reissued equivalent must be used for submissions for this initiative.
Due Date: applications will be accepted on a rolling basis from May 15, 2020 to January 25, 2022.
|
NOT-MD-20-019
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
| NIMHD
NIA
NIMH
| Administrative supplement work that is proposed through
PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935.
Due Date: applications will be accepted on a rolling basis from May 01, 2020 through May 01, 2021.
-
NOT-MD-20-024:
Notice of Information for Date of Submission to NOT-MD-20-019 and NIMHD Consideration for FY Award informs that all applications received by 5:00 PM on July 15, 2020 will be considered for funding in FY2020. Applications to NIMHD which are received after 5:00 PM (local time of the applicant institution) on July 15, 2020 may be held for consideration in Fiscal Year 2021 and not be eligible for funding before October 2020
|
NOT-EB-20-008
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
| NIBIB
| Applications in response to this NOSI must be submitted using one of the following target opportunities or subsequently reissued equivalents:
PA-20-135, which is intended to provide funds for NIH grantees applying to expand the scope of their active grant and are limited to the following mechanisms: DP1, DP2, P41, R00, R01, R03, R15, R21, R24, R37, R41, R43, R44, R56, U01, U18, U24, U2C, U54, UG3, UH2, UH3.
PA-20-272, which is intended to provide additional funds for NIH grantees for work that falls within the scope of their active grant.
Due Date: applications will be accepted immediately and on a rolling basis through November 10, 2020.
|
NOT-ES-20-020
| Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
| NIEHS
| This replaced
NOT-ES-20-015.
Administrative supplement work that is proposed through PA-18-591 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935. If you are applying for a new R21 grant that does not build off of an existing NIEHS grant, apply to
RFA-ES-19-011. Due Date: application Due Dates for all programs:
May 1, 2020; June 1, 2020; July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; May 3, 2021.
|
NOT-OD-20-097
|
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
| OBSSR
NHLBI
NIA
NIAAA
NIDDK
NIEHS
NCCIH
NCI
| Administrative supplement work that is proposed through
PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through
PA-18-935.
Due Date: applications will be accepted on a rolling basis through March 31, 2021.
|
NOT-AA-20-011
|
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA
| NIAAA
| Administrative supplement work that is proposed through
PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through
PA-18-935.
Due Date: applications will be accepted on a rolling basis through April 15, 2021.
|
NOT-TR-20-028
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
| NCATS
| CTSA (CTRI) award specific.
Due Date: applications will be accepted immediately and on a rolling basis through November 10, 2020.
|
NOT-DC-20-008
| Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
| NIDCD
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
-
PA-18-334 - NIDCD Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
-
PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
-
PA-20-184 – NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
-
PA-20-196 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
-
PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
-
PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Due Date: This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022
|
NOT-MH-20-053
| Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
| NIMH
NEI
NHLBI
NIA
NIAAA
NICHD
NIDCD
NIDCR
NIDDK
NIDA
NINR
NIMHD
NCCIH
NCATS
The following NIH Offices may co-fund applications assigned to those I/Cs:
| Administrative supplement work that is proposed through
PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through
PA-18-935. Due Date: applications will be accepted on a rolling basis from June 10, 2020 through December 15, 2020, by 5:00 PM local time of applicant organization.
- Applications submitted before July 15, 2020 will be considered for funding in in Fiscal Year 2020; and applications received after July 16, 2020 may be held for consideration in Fiscal Year 2021 and not be eligible for funding until October 2020.
|
NOT-MD-20-022
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
| NEI
NHLBI
NIA
NIAAA
NICHD
NIDCD
NIDCR
NIDDK
NIDA NIEHS
NIMH
NCCIH
NCATS
The following NIH Offices may co-fund applications assigned to those I/Cs:
| Administrative supplement work that is proposed through PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935. Due Date: applications will be accepted on a rolling basis from June 10, 2020 through December 15, 2020 by 5:00 PM local time of the applicant organization. This NOSI expires on December 30, 2020. - Applications submitted before July 15, 2020 will be considered for funding in in Fiscal Year 2020; and applications received after July 16, 2020 may be held for consideration in Fiscal Year 2021 and not be eligible for funding until October 2020.
|
NOT-TR-20-029
| Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need
| NCATS
| CTSA (CTRI) award specific.
Administrative supplement work that is proposed through
PA-20-272 must be within the general scope of the research or training that is already supported. Due Date: applications will be accepted immediately and on a rolling basis through November 10, 2020
|
NOT-OD-20-129
|
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
| OD
NHLBI
NHGRI
NIA
NIAID
NIAMS
NICHD
NIDCD
NIDCR
NIDDK
NIEHS
NINDS NIMHD
NCCIH
NCATS
ORIP
NCI |
Administrative supplement work that is proposed through PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935.Due Date: July 13, 2020, November 12, 2020, March 12, 2021, and July 12, 2021
|
NOT-AI-20-059
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
| NIAID
| Applications in response to this NOSI must be submitted using the Emergency Competitive Revision to Existing NIH Awards: PA-20-135 (or its subsequent reissued equivalents). Due Date: applications will be accepted on a rolling basis 07/02/2020 to 07/02/2021.
|
NOT-AI-20-065
| Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
| NIAID
|
Applications in response to this NOSI must be submitted using PAR-18-633 NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) (or its subsequent reissued equivalents).
Due Date: September 14, 2020; October 14, 2020; November 14, 2020; December 14, 2020; January 14, 2021; February 14, 2021; March 14, 2021; April 14, 2021; May 14, 2021; June 14, 2021; July 14, 2021; ; August 14, 2021; and September 14, 2021. |
NOT-NS-20-051
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
| NINDS
| Applications for this initiative must be submitted using one of the following opportunity announcements or the subsequent reissued equivalent.
PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through
PA-18-935. Due Date: applications will be accepted on a rolling basis from April 15, 2020 to April 14, 2021
|
NOT-DC-20-008
|
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
| NIDCD
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
-
PA-18-334 - NIDCD Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
-
PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
-
PA-20-184 – NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
-
PA-20-196 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
-
PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
-
PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Due Date: this notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022
|
NOT-MD-20-025
|
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities
| NIMHD
NCI
NIDA
NLM
NIMH
NIAMS
The following NIH Offices may co-fund applications assigned to those I/Cs:
ODP
OBSSR
| Submit applications for this initiative using the following funding opportunity announcement (FOA) or any reissue of thid announcement through the expiration date of this notice:
-
PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: this notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through May 8, 2023.
|
NOT-HL-20-814
| Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
| NHLBI
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:
-
PA-20-183 Research Project Grant (Parent R01 Clinical Trial Required)
-
PA-20-185 Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: dates on or after October 5, 2020 and subsequent receipt dates through July 5, 2024 of reissued FOAs.
|
NOT-TR-21-006
| Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
| NCATS
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice: - PAR-17-465 Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)
- PAR-18-462 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34 Clinical Trial Not Allowed)
- PAR-18-332 Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)
Due Date: dates on or after October 30, 2020 and subsequent receipt dates through March 16, 2021
|
NOT-DA-20-084
| Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:
-
PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
-
PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
-
PA-20-195 - NIH Exploratory/Developmental Research Grant (Parent R21Clinical Trial Not Allowed)
|